| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/21/2007 | CN1931877A Prepn and use of CD20 antagonizing Chimeric antibody |
| 03/21/2007 | CN1931876A Total monoclonal antibody of AIDS-resisting surface glucoprotein and its prepn process |
| 03/21/2007 | CN1931373A Correlation of cofilin 1 and resistance to anticancer taxane chemotherapy medicine |
| 03/21/2007 | CN1306272C In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 03/21/2007 | CN1306271C Agent for detecting cancer's ability to metastasize |
| 03/21/2007 | CN1305906C Use of antibodies against specific MHC-Peptide complexes |
| 03/21/2007 | CN1305905C Humanized antibody and process for preparing same |
| 03/21/2007 | CN1305904C Human anti-tetanotoxin monoclonal antibody, method for preparation and application |
| 03/21/2007 | CN1305898C Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 03/21/2007 | CN1305896C Protein purification by ion exchange chromatography |
| 03/21/2007 | CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 03/20/2007 | US7193066 Proteolytically treated holotoxin of clostridial neurotoxin is purified by immunoaffinity chromatography or matched ion polynucleotide chromatography |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7193064 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells |
| 03/20/2007 | US7193063 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in esophageal tumor, normal stomach and melanoma |
| 03/20/2007 | US7193062 Antibodies to a polypeptide encoded by a nucleic acid over expressed in esoprageal and lung tumor, and under expressed in kidney tumor and melanoma |
| 03/20/2007 | US7193061 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/20/2007 | US7193060 Antibodies to a polypeptides encoded by a nucleic acid overexpressed in kidney tumor and underexpressed in lung tumor |
| 03/20/2007 | US7193059 Antibodies that recognize a polypeptide overexpressed in rectal tumors |
| 03/20/2007 | US7193058 Monoclonal antibody which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/20/2007 | US7193057 Antibodies to a polypeptide encoded by a nucleic acid underexpressed in rectal tumor |
| 03/20/2007 | US7193051 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 03/20/2007 | US7193045 Nucleotide sequences coding polypeptide for use in diagnostics biosensors and thrombolytic agents |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192924 Corticotropin releasing factor 2 receptor agonists |
| 03/20/2007 | US7192923 For therapy and prophylaxis of muscular dystrophy |
| 03/20/2007 | US7192917 treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising administering an antagonist to high mobility group 1 protein |
| 03/20/2007 | US7192722 Phenethanolamine-derived haptens, immunogens, antibodies and conjugates |
| 03/20/2007 | US7192719 Antibodies specific for papillary fibroblasts as markers for skin quality |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |
| 03/20/2007 | US7192711 using tumor-associated genes and encoded gene products in tumor diagnosis |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192704 Methods for detection and treatment of neural cancers |
| 03/20/2007 | US7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins |
| 03/20/2007 | US7192586 Topical administration of an anti-PSMA antibody alone or conjugated to a cytotoxic moiety to the extracellular domain of human prostate specific membrane antigen (PSMA); anti-proliferative agents and - carcinogenic agents |
| 03/20/2007 | US7192585 Inhibiting or preventing T cell/B cell interactions associated with Crohn's disease comprising administering an amount of a monoclonal anti-CD80 antibody |
| 03/20/2007 | US7192584 Therapy of psoriasis in a human comprising administering human necrosis factor (TNF)-inhibiting amount of an anti-TNF antibody, wherein anti-TNF antibody competitively inhibits binding of TNF to monoclonal antibody cA2 |
| 03/20/2007 | US7192583 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | CA2223080C Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/15/2007 | WO2007030244A2 An ultra-high yield intravenous immune globulin preparation |
| 03/15/2007 | WO2007030012A2 Extracellular matrix imaging |
| 03/15/2007 | WO2007028985A2 Adjuvanted vaccine |
| 03/15/2007 | WO2007028592A1 Influencing cardial fc-receptors for treating dilatative cardiomyopathy |
| 03/15/2007 | WO2006133164A3 Anti-trkb monoclonal antibodies and uses thereof |
| 03/15/2007 | WO2006121422A3 Antibodies against clostridium difficile toxins and uses thereof |
| 03/15/2007 | WO2006099451A3 Novel human, feline, chicken and other animal interferons and uses thereof |
| 03/15/2007 | WO2006097689A3 Antibodies against candida antigens |
| 03/15/2007 | WO2006059110A3 Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| 03/15/2007 | WO2006021874A8 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/15/2007 | WO2003093432A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/15/2007 | WO2003082006A3 Methods and compositions for preventing obesity and obesity related disorders |
| 03/15/2007 | US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors |
| 03/15/2007 | US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061903 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste |
| 03/15/2007 | US20070061901 Methods to inhibit growth of prostate cancer cells |
| 03/15/2007 | US20070061900 Methods of modifying eukaryotic cells |
| 03/15/2007 | US20070060743 For diagnostics, forensics, gene mapping; identification of mutations responsible for genetic disorders or other traits, to assess biodiversity, and to produce many other types of data and products dependent on DNA and amino acid sequences |
| 03/15/2007 | US20070060742 for new human tumor necrosis factor receptor designated as Ztnfr12; usefulness in both basic research and as therapeutics |
| 03/15/2007 | US20070060741 Method of weak partitioning chromatography |
| 03/15/2007 | US20070060539 Shc proteins as therapeutic targets in proliferative diseases |
| 03/15/2007 | US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 03/15/2007 | US20070059803 Mammalian cytokines; related reagents and methods |
| 03/15/2007 | US20070059793 Nogo receptor binding protein |
| 03/15/2007 | US20070059784 Methods for measuring the insulin receptor alpha subunit |
| 03/15/2007 | US20070059771 Protein O-sulfonation |
| 03/15/2007 | US20070059767 Method of identifying N-terminal proBNP |
| 03/15/2007 | US20070059766 Mixture of binding proteins |
| 03/15/2007 | US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070059758 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 03/15/2007 | US20070059756 Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies |
| 03/15/2007 | US20070059738 Administering to host a therapeutically effective amount of an agent which prevents the interaction of mucosal addressin cell adhesion molecule-1 with a ligand therefor |
| 03/15/2007 | US20070059729 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059721 MAGI polynucleotides, polypeptides, and antibodies |
| 03/15/2007 | US20070059681 Method for production of bioresorable microparticles, microparticles thus obtained and use thereof |
| 03/15/2007 | US20070059316 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents |
| 03/15/2007 | US20070059313 Homogeneous preparations of il-28 and il-29 |
| 03/15/2007 | US20070059312 Anti-vegf antibodies |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/15/2007 | US20070059308 efficient, high throughput screening of antibody libraries against proteins targets; for screening a diverse antibody library for antibodies that bind to a membrane protein such as a chemokine receptor in yeast |
| 03/15/2007 | US20070059307 Biological products |
| 03/15/2007 | US20070059305 Neutralizing human anti-IGFR antibody |
| 03/15/2007 | US20070059304 Anti-TrkB monoclonal antibodies and uses thereof |
| 03/15/2007 | US20070059303 monoclonal antibody for prevention and treatment of allergies, asthma, crohn's and lymes disease, arthritis, diabetes, glomerularnephritis, vision defects, skin disorders, sarcoidosis and viral diseases |
| 03/15/2007 | US20070059301 Modified antibody fragments |
| 03/15/2007 | US20070059282 Immunocytokine sequences and uses thereof |
| 03/15/2007 | US20070059280 Inhibitors of colony stimulating factors |
| 03/15/2007 | US20070059275 Antibody toxin conjugates |
| 03/15/2007 | US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent |
| 03/15/2007 | CA2662798A1 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 03/15/2007 | CA2621666A1 Antigens for vaccination against and detection of mycoplasma suis |
| 03/15/2007 | CA2621502A1 Toxin conjugated eph receptor antibodies |
| 03/15/2007 | CA2621025A1 An ultra-high yield intravenous immune globulin preparation |
| 03/14/2007 | EP1762623A1 Methods for producing biologically active peptide dimers |
| 03/14/2007 | EP1762619A2 Multiple-tumor aberrant growth genes |